Cognitive disorders in Parkinson's disease: Confirmation of a spectrum of severity

Parkinsonism and Related Disorders

Volumn 21, Issue 11, 2015, Pages 1299-1305

  Dujardin, Kathy ^a,b   Moonen, Anja J H ^c   Behal, Hélène ^b   Defebvre, Luc ^a,b   Duhamel, Alain ^b   Duits, Annelien A ^c   Plomhause, Lucie ^a,b   Tard, Celine ^a   Leentjens, Albert F G ^c  

^a CHU Lille   (France)

^b UNIV LILLE   (France)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Behavior; Cluster analysis; Cognition; Dementia

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGED; ARTICLE; CLUSTER ANALYSIS; COGNITIVE DEFECT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISCRIMINANT ANALYSIS; DISEASE SEVERITY; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PERIPHERAL VASCULAR DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; UNIFIED PARKINSON DISEASE RATING SCALE; VERBAL MEMORY; WORKING MEMORY; CLINICAL TRIAL; COGNITION DISORDERS; COMPLICATION; MEMORY DISORDERS; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

AGED; CLUSTER ANALYSIS; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 84946479049     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.08.032     Document Type: Article

References (29)

1. Litvan I., Aarsland D., Adler C.H., Goldman J.G., Kulisevsky J., Mollenhauer B., et al. MDS task force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov. Disord. 2011, 26:1814-1824. 10.1002/mds.23823.
2. Muslimovic D., Post B., Speelman J.D., Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005, 65:1239-1245. 10.1212/01.wnl.0000180516.69442.95.
3. Janvin C., Aarsland D., Larsen J.P., Hugdahl K. Neuropsychological profile of patients with Parkinson's disease without dementia. Dement. Geriatr. Cogn. Disord. 2003, 15:126-131.
4. Dujardin K., Leentjens A.F.G., Langlois C., Moonen A.J.H., Duits A.A., Carette A.-S., Duhamel A. The spectrum of cognitive disorders in Parkinson's disease: a data-driven approach. Mov. Disord. 2013, 28:183-189. 10.1002/mds.25311.
5. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatr. 1988, 51:745-752.
6. Morris J.C. The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
7. Emre M., Aarsland D., Brown R., Burn D.J., Duyckaerts C., Mizuno Y., et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov. Disord. 2007, 22. 1689-707- quiz 1837. 10.1002/mds.21507.
8. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. Geriatric Psychiatry 1976, 77-121. Grune and Stratton, New York. L. Bellak, T. K. (Eds.).
9. Wechsler D. WAIS-R: Wechsler Adult Intelligence Scale, Revised 1986.
10. Smith A. Symbol Digits Modalities Test 1982, Western Psychological Services, Los Angeles.
11. Reitan R.M. TMT, Trail Making Test A & B, South Tucson 1992.
12. Brandt J., Benedict R. Hopkins Verbal Learning Test-revised 2001, Psychological Assessment Resources, Lutz, FL.
13. Graves R.E., Bezeau S.C., Fogarty J., Blair R. Boston naming test short forms: a comparison of previous forms with new item response theory based forms. J. Clin. Exp. Neuropsychol. 2004, 26:891-902. 10.1080/13803390490510716.
14. Benton A.L., Varney N.R., Hamsher K.D. Visuospatial judgment. A clinical test. Arch. Neurol. 1978, 35:364-367.
15. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov. Disord. 2010, 25:2649-2653. 10.1002/mds.23429.
16. Goetz C.G., Tilley B.C., Shaftman S.R., Stebbins G.T., Fahn S., Martinez-Martin P., et al. Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 2008, 23:2129-2170. 10.1002/mds.22340.
17. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatr. 1960, 23:56-62.
18. Sockeel P., Dujardin K., Devos D., Deneve C., Destée A., Defebvre L. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J. Neurol. Neurosurg. Psychiatr. 2006, 77:579-584. 10.1136/jnnp.2005.075929.
19. Leentjens A.F.G., Dujardin K., Pontone G.M., Starkstein S.E., Weintraub D., Martinez-Martin P. The Parkinson anxiety scale (PAS): development and validation of a new anxiety scale. Mov. Disord. 2014, 29:1035-1043. 10.1002/mds.25919.
20. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9:179-186.
21. Litvan I., Goldman J.G., Tröster A.I., Schmand B.A., Weintraub D., Petersen R.C., et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Mov. Disord. 2012, 27:349-356. 10.1002/mds.24893.
22. Kehagia A.A., Barker R.A., Robbins T.W. Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis. Neurodegener. Dis. 2013, 11:79-92. 10.1159/000341998.
23. Uc E.Y., McDermott M.P., Marder K.S., Anderson S.W., Litvan I., Como P.G., et al. Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology 2009, 73:1469-1477. 10.1212/WNL.0b013e3181bf992f.
24. Anang J.B.M., Gagnon J.-F., Bertrand J.-A., Romenets S.R., Latreille V., Panisset M., et al. Predictors of dementia in Parkinson disease: a prospective cohort study. Neurology 2014, 83:1253-1260. 10.1212/WNL.0000000000000842.
25. Zhu K., van Hilten J.J., Marinus J. Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG. Park. Relat. Disord. 2014, 20:980-985. 10.1016/j.parkreldis.2014.06.006.
26. Hu M.T.M., Szewczyk-Królikowski K., Tomlinson P., Nithi K., Rolinski M., Murray C., et al. Predictors of cognitive impairment in an early stage Parkinson's disease cohort. Mov. Disord. 2014, 29:351-359. 10.1002/mds.25748.
27. Dujardin K., Sockeel P., Delliaux M., Destée A., Defebvre L. Apathy may herald cognitive decline and dementia in Parkinson's disease. Mov. Disord. 2009, 24:2391-2397. 10.1002/mds.22843.
28. Aarsland D., Taylor J.-P., Weintraub D. Psychiatric issues in cognitive impairment. Mov. Disord. 2014, 29:651-662. 10.1002/mds.25873.
29. McKinlay A., Grace R.C., Dalrymple-Alford J.C., Roger D. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease. Dement. Geriatr. Cogn. Disord. 2009, 28:121-129. 10.1159/000235247.